StockData

NextCure, Inc. (NXTC) stock

NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$6.88+0.18 (+2.76%)

Close on Nov 18, 2026Market cap $31.52MP/E –Yield 0.00%

NextCure shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

NextCure's shares outstanding was 5M at Jun 30, 2026. For fiscal 2025 it was 3M, up 22.0% from the year before. The highest annual figure on record is 3M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20253M+22.0%
FY2024Dec 31, 20242M+0.5%
FY2023Dec 31, 20232M+0.3%
FY2022Dec 31, 20222M+0.5%
FY2021Dec 31, 20212M+0.3%
FY2020Dec 31, 20202M+75.4%
FY2019Dec 31, 20191M+1045.8%
FY2018Dec 31, 20180M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20265M+123.6%
Q1 FY2026Mar 31, 20265M+124.5%
Q4 FY2025Dec 31, 20254M+70.6%
Q3 FY2025Sep 30, 20253M+14.8%
Q2 FY2025Jun 30, 20252M+1.9%
Q1 FY2025Mar 31, 20252M+0.4%
Q4 FY2024Dec 31, 20242M+0.4%
Q3 FY2024Sep 30, 20242M+0.5%
Q2 FY2024Jun 30, 20242M+0.5%
Q1 FY2024Mar 31, 20242M+0.5%
Q4 FY2023Dec 31, 20232M+0.5%
Q3 FY2023Sep 30, 20232M+0.3%
Q2 FY2023Jun 30, 20232M+0.3%
Q1 FY2023Mar 31, 20232M+0.2%
Q4 FY2022Dec 31, 20222M+0.5%
Q3 FY2022Sep 30, 20222M+0.5%
Q2 FY2022Jun 30, 20222M+0.5%
Q1 FY2022Mar 31, 20222M+0.4%
Q4 FY2021Dec 31, 20212M+0.3%
Q3 FY2021Sep 30, 20212M+0.2%
Q2 FY2021Jun 30, 20212M+0.3%
Q1 FY2021Mar 31, 20212M-6.0%
Q4 FY2020Dec 31, 20202M+10.4%
Q3 FY2020Sep 30, 20202M+21.3%
Q2 FY2020Jun 30, 20202M+103.9%
Q1 FY2020Mar 31, 20202M+2027.6%
Q4 FY2019Dec 31, 20192M+1719.1%
Q3 FY2019Sep 30, 20192M+1559.0%
Q2 FY2019Jun 30, 20191M+885.9%
Q1 FY2019Mar 31, 20190M+0.7%
Q4 FY2018Dec 31, 20180M–
Q3 FY2018Sep 30, 20180M–
Q2 FY2018Jun 30, 20180M–
Q1 FY2018Mar 31, 20180M–

More NextCure figures

See a number that looks wrong?